JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M501477200 on February 18, 2005

J. Biol. Chem., Vol. 280, Issue 17, 16987-16993, April 29, 2005
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/17/16987    most recent
M501477200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Urschel, S.
Right arrow Articles by Duyster, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Urschel, S.
Right arrow Articles by Duyster, J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Phosphorylation of Grb10 Regulates Its Interaction with 14-3-3*

Susanne Urschel, Florian Bassermann, Ren-Yuan Bai, Silvia Münch, Christian Peschel, and Justus Duyster{ddagger}

From the Department of Internal Medicine III, Laboratory of Leukemogenesis, Technical University of Munich, 81675 Munich, Germany

Received for publication, February 8, 2005


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Grb10 is a member of adapter proteins that are thought to play a role in receptor tyrosine kinase-mediated signal transduction. Grb10 expression levels can influence Akt activity, and Grb10 may act as an adapter involved in the relocalization of Akt to the cell membrane. Here we identified 14-3-3 as a binding partner of Grb10 by employing a yeast two-hybrid screen. The 14-3-3·Grb10 interaction requires phosphorylation of Grb10, and only the phosphorylated form of Grb10 co-immunoprecipitates with endogenous 14-3-3. We could identify a putative phosphorylation site in Grb10, which is located in a classical 14-3-3 binding motif, RSVSEN. Mutation of this site in Grb10 diminished binding to 14-3-3. Thus, Grb10 exists in two different states of phosphorylation and complexes with 14-3-3 when phosphorylated on serine 428. We provide evidence that Akt directly binds Grb10 and is able to phosphorylate Grb10 in an in vitro kinase assay. Based on these findings, we propose a regulatory circuitry involving a phosphorylation-regulated complex formation of Grb10 with 14-3-3 and Akt.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Grb10 is a member of adapter proteins that include Grb7 and Grb14 (1). These adapter proteins share similar structural organizations, including an N-terminal proline-rich region, a central segment named the GM region (1) with a PH1 domain, and a C-terminal Src homology 2 (SH2) domain. Grb10 associates with a variety of growth factors at the cell surface, such as the insulin growth factor receptor (2), and with intracellular protein kinases like Raf1 and MEK1 (3) via its SH2 domain. Serine/threonine phosphorylation of Grb10 in response to insulin (4), as well as tyrosine phosphorylation in response to Tec (5) and Src (6), has been described. Interestingly, previously reported data have shown that the incubation with wortmannin, a PI 3-kinase inhibitor, abolishes Grb10 phosphorylation (4), implicating a kinase downstream of the PI 3-kinase pathway as being responsible for Grb10 phosphorylation.

The finding of four different splicing variants of Grb10 (human Grb10{alpha}, {beta}, {gamma}, and {delta}) may explain the controversy about the specific role of Grb10 as an activator or an inhibitor in particular signal transduction processes (7). Three isoforms ({beta}, {gamma}, and {delta}) of Grb10 contain an intact PH domain, and one isoform lacks a PH domain (4). Our laboratory has demonstrated that overexpression of a Grb10 isoform with an intact PH domain leads to Akt activation (7), whereas overexpression of Grb10 lacking an intact PH domain abolishes this activation. These data indicated the necessity of the Grb10 PH domain for its stimulatory effect on Akt. In accordance with this hypothesis, overexpression of a Grb10 isoform with an intact PH domain has a positive, stimulatory, and mitogenic effect on platelet-derived growth factor-BB, insulin growth factor-1, and insulin action (8). Expression of a Grb10 isoform lacking the PH domain inhibits insulin-stimulated substrate tyrosine phosphorylation and the activation of PI 3-kinase (9). Therefore, the natural occurrence of different Grb10 isoforms with and without an intact PH domain may provide a mechanism for different regulation of signal transduction processes. However, recent additional studies showed controversial results regarding the role of Grb10 with an intact PH domain in insulin signaling (10–12). The use of different cellular systems may account for these differences.

Interestingly, the fusion of Grb10 to Akt revealed a constitutive active Akt chimera, further suggesting an important role of Grb10 in Akt regulation (7). In addition, a Grb10 mutant, which is constitutively attached to the plasma membrane, induced strong Akt activation and had a potent anti-apoptotic effect in Ba/F3 cells grown without survival factors.2 Together, these data suggest a mechanism of Akt activation through Grb10. Because Akt activation is a multistep process that requires the membrane translocation of the protein, Grb10 may act as a vehicle for Akt that facilitates the membrane localization of Akt. One of the first identified substrates of Akt was the Bcl2 family member Bad (13). Akt phosphorylation of Bad mediates its interaction with 14-3-3, which prevents Bad from binding to Bcl-XL and suppresses apoptosis (14). Another substrate of Akt is FKHRL1, a member of the Forkhead family of transcription factors (15). Akt phosphorylates FKHRL1 in the presence of survival factors, leading to FKHRL1 binding to 14-3-3. Binding to 14-3-3 causes cytosolic sequestration of FKHRL1 and prevents the nuclear translocation of FKHRL1. Survival factor withdrawal mediates the dephosphorylation and nuclear translocation of FKHRL1, where the expression of pro-apoptotic molecules such as the Fas ligand is initiated by FKHRL1. In both cases, the pro-apoptotic function of these proteins is suppressed by interaction with 14-3-3, mediating sequestration in an appointed cell compartment.

The interest in 14-3-3 in recent years has increased intensively because of the important interaction partners of 14-3-3 that are involved in cell cycle regulation (Cdc25), transcriptional control of gene expression (FKHRL members), or apoptosis (Bad). 14-3-3 proteins are highly conserved and ubiquitously expressed, and there exist to date seven isoforms in human cells and up to 15 in plants. These proteins generate homodimers and heterodimers (16, 17) and bind discrete phosphoserine/threonine motifs (18, 19). Three preferred binding motifs of 14-3-3 have been described, namely Arg-Ser-X-Ser(P)-X-Pro, Arg-X-Arg-X-X-Ser(P)-X-Pro, and Arg-X-X-Ser(P), where Ser(P) represents a phosphorylated serine. Most of the interaction partners of 14-3-3 contain one of these motifs. But association with proteins that do not contain either one of these motifs, e.g. protein kinase Cµ, and association with unphosphorylated proteins, such as exoenzyme S, has been described (20, 21).

In the present study we identified 14-3-3 as an interaction partner of Grb10. Phosphorylation of Grb10 is required for its interaction with 14-3-3 and is mediated by a 14-3-3 consensus binding site in Grb10. Based on these findings we present a hypothetical model of regulatory circuitry in which the phosphorylation of Grb10 regulates its interaction with 14-3-3 and Akt.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Cell Lines, Expression Constructs, and Transfections—293, COS1, COS7, HeLa, and U2OS cells were maintained in Dulbecco's modified Eagle's medium with 10% FCS. Ba/F3 cells were incubated in RPMI medium containing 10% FCS and murine interleukin-3.

The murine Grb10 cDNA (pRK5 Grb10) was kindly provided by Renato Baserga of the Kimmel Cancer Institute, Philadelphia, PA. The human Grb10 cDNA (pBEX Grb10 gamma) was a kind gift from Feng Liu of the Department of Pharmacology, University of Texas Health Science Center, San Antonio, TX. To obtain a FLAG-tagged murine Grb10, the cDNA was cloned into pCMVTag from Stratagene. For mutation of the Grb10 Ser-76 and Ser-428, the serine was changed to alanine by site-directed mutagenesis using appropriate primers.

The 14-3-3 cDNA was isolated from the yeast DNA and cloned into pCMV-Myc tagged from Stratagene. To obtain higher expression levels, we cloned the Myc-tagged 14-3-3 cDNA into a pcDNA 3.1 vector (Invitrogen).

The hemagglutinin-tagged protein kinase B-Akt construct (pCMV6 HA-Akt) was a kindly gift from Thomas Franke, Department of Pharmacology, Columbia University, New York, NY. 293 cells were transiently transfected with M-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethyl-ammonium methyl-sulfate (DOTAP liposomal transfection reagent; Roche Applied Science). COS1 and COS7 cells were transiently transfected with Gene Porter (GTS Inc., Biozol GmbH, Eching, Germany). Ba/F3 cells were stably transfected by electroporation and selection with 1 mg/ml G418 as described previously (22) (Calbiochem).

In Vivo Labeling of Cells with 32Pi—HeLa cells either starved in 0.5% FCS, stimulated with 10% FCS, or treated with 0.5 µM okadaic acid (OA) were cultured in phosphate-free Dulbecco's modified Eagle's medium containing 0.2 mCi/ml 32Pi (Amersham Biosciences) for 2 h at 37 °C. Immunoprecipitations were performed from the corresponding lysates using either anti-Grb10 (Upstate Biotechnology, Lake Placid, NY) or control antiserum.

In Vitro Translation—In vitro translation was performed with the TNT-coupled reticulocyte lysate system (Promega, Madison, WI) and [35S]methionine.

In Vitro Kinase Assay—Glutathione S-transferase (GST)-Grb10 and Bad (Upstate Biotechnology) were incubated with active Akt, inactive Akt, or buffer alone, and the kinase assay was performed with 32P according to the manufacturer's instructions (Upstate Biotechnology). The reactions were resolved by SDS-Page and visualized by autoradiography (BioMax, Kodak).

Yeast Two-hybrid System—The DNA of Grb10 was cloned with BamHI/SalI into the yeast expression vector BTM116 BamHI/XhoI. A cDNA library derived from K562 cells was used (Clontech) as prey. Interactions were tested in the L40 yeast strain by assaying activation of the HIS3 reporter as described preciously (22).

Antibody Preparation—To generate the antiphospho-Grb10 antibody, a phosphopeptide corresponding to amino acids 423–436 of the human Grb10 cDNA sequence was used to raise polyclonal antibodies in rabbits (Davids Biotechnology, Regensburg, Germany). The resulting serum was affinity purified using both the cognate phosphopeptide and the non-phosphopeptide.

Immunoprecipitations and Western Blotting—Immunoprecipitation and immunoblotting were performed in accordance with standard procedures as described previously (23) with the following antibodies: agarose-coupled anti-FLAG M2 (Sigma), mouse anti-FLAG M2 (Stratagene), anti-Myc 9E11 (Sigma), anti-14-3-3{beta} K19 (Santa Cruz Biotechnology, Santa Cruz, CA), anti-14-3-3{beta} H8 (Santa Cruz Biotechnology), anti-Grb10 (Upstate Biotechnology), and goat anti-Akt C-20 (Santa Cruz Biotechnology). The phospho-specific Akt antibody (Ser-473) was obtained from New England Biolabs.

For co-immunoprecipitation in tissues, the proteins were extracted from mouse lung by homogenization. The experiment was as described by O'Kelly et al. (24). The immunoprecipitation was performed with 5 µg of a polyclonal anti-Grb10 antibody or a control antibody. The immunocomplexes were isolated with 40 µl of protein A beads. The proteins were separated with SDS-PAGE (12% for 14-3-3 and 8% for Grb10 separation). Blots were developed using SuperSignal chemoluminescent substrates from Pierce.

GST Fusion Construct and GST Binding Studies—The 14-3-3 cDNA was cloned into the pGEX vector to obtain a GST-14-3-3 construct. The procedure for pull-down assays has been described previously (22). Cell lysates were incubated with the GST fusion construct or with GST alone. Bound fractions of recombinant proteins were separated by SDS-PAGE. A purified GST fusion protein of full-length Akt was obtained from a commercial source (Upstate Biotechnology).

Treatment with Phosphatase, Wortmannin, or Okadaic Acid—Cells were transfected and harvested, and immunoprecipitation experiments were performed. The bound fractions were washed with phosphatase buffer (Pipes, pH 6) and incubated for the indicated time points at 30 °C with 0.4 units phosphatase (Sigma) with or without phosphatase inhibitors (NaF, ortho-vanadate, and glycerol phosphate). Cells were incubated with OA (Roche, Mannheim, Germany) for the indicated time points at the described concentrations (Fig. 1, C and D).



View larger version (35K):
[in this window]
[in a new window]
  		FIG. 1.
Akt directly binds and phosphorylates Grb10. A, the binding affinity of 35S-labeled, in vitro translated Grb10 WT and Grb10 {Delta}PH to Akt was tested. 35S-labeled Grb10 was precipitated by GST-Akt, and interaction was visualized by autoradiography. B, GST-Grb10 was incubated with active Akt (1), inactive Akt (2), or with reaction buffer alone (3) in the presence of [{gamma}-32P]ATP in kinase buffer. The reaction products were separated by SDS-PAGE, and the incorporation of 32P was measured by autoradiography (top section). Equal levels of GST proteins were visualized by Coomassie staining (bottom section). C, COS1 cells transiently expressing Grb10 were incubated with OA and harvested at the indicated time points. D, cells expressing Grb10 or Bad (as a control) were incubated with different concentrations of OA to identify the phosphatase responsible for Grb10 dephosphorylation. E, HeLa cells that had been serum-starved, stimulated with FCS, or treated with okadaic acid were incubated with 32Pi for 2 h in phosphate-free Dulbecco's modified Eagle's medium. Thereafter, immunoprecipitations (IP) using either Grb10 antiserum (Upstate Biotechnology) or control antiserum were performed from the respective lysates. An autoradiogram of the precipitated fractions is shown. F, a phospho-specific Grb10 antibody ({alpha} P-Grb10) was used to detect phosphorylated Grb10 (P-Grb10) in immunoprecipitates (IP) from either serum-starved or FCS-stimulated HeLa cells using polyclonal Grb10 antiserum (Upstate Biotechnology). G, Western blot analysis of HeLa lysates treated as indicated was performed using the phospho-specific Grb10 antiserum. Addition of the cognate phosphopeptide was performed to demonstrate specificity. The anti-Grb10 antibody ({alpha} Grb10) (Upstate Biotechnology) detects the levels of Grb10 expression in the respective lysates. IB, immunoblot.

 
Cells were incubated for 30 min in Dulbecco's modified Eagle's medium lacking FCS containing 500 nM wortmannin (Sigma). Untreated cells were incubated in media containing the same concentration of Me2SO.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
The Serine/Threonine Kinase Akt Interacts Directly with the Adapter Protein Grb10 and Phosphorylates Grb10 in Vitro— First we wanted to determine whether the described coimmunoprecipitation between Grb10 and Akt is a direct interaction between the two proteins (7). We performed GST pull-downs with in vitro translated, 35S-labeled Grb10 and purified GSTAkt protein (Fig. 1A). Both, Grb10WT and Grb10{Delta}PH showed a specific and direct interaction with Akt (Fig. 1A).

We noted previously a mobility shift of Grb10 in SDS gels in Mo7e and K562 cells expressing the c-kit receptor or Bcr-Abl (7), respectively. Other groups reported tyrosine phosphorylation of Grb10 as an effect of Tec (5), as well as serine phosphorylation in response to insulin stimulation (4). Additional data revealed that incubation with wortmannin, an inhibitor of the PI 3-kinase/Akt pathway, abolished phosphorylation of Grb10, implicating a kinase downstream of this pathway (4, 7). Because of their direct association, we assumed that Akt itself may be the kinase phosphorylating Grb10. In vitro kinase assays were performed with GST-Grb10 and with kinase active and inactive Akt. Bad, a known substrate of Akt, was used as a positive control (13) (Fig. 1B, top section). The autoradiogram showed that GST-Grb10 incorporated 32P in the presence of kinase-active Akt. In this assay, the phosphorylation intensity was comparable with the phosphorylation of Bad (Fig. 1B). In the presence of kinase-inactive Akt, no 32P signal could be detected. Coomassie staining of the gel demonstrated equal levels of GST-Grb10 (Fig. 1B, bottom section). Thus, we identified Akt as a kinase able to phosphorylate Grb10 in an in vitro kinase assay.

Phosphorylation is often regulated by a balance of kinases and phosphatases. Okadaic acid is a potent inhibitor of the protein phosphatases PP1 and PP2A. Okadaic acid causes a 2.5–3-fold higher phosphorylation of many proteins (27), because the balance shifts in favor of phosphorylation. To investigate whether Grb10 phosphorylation is affected by phosphatase inhibitors, we treated COS1 cells expressing Grb10 with OA and harvested the cells after different time points (Fig. 1C). Western blot analysis showed that after 40 min of incubation with OA, Grb10 started to undergo a mobility shift (Fig. 1C, lane labeled +40min). It is known that OA inhibits PP1 in the micromolar range and PP2A in the nanomolar range (27). We transfected COS1 cells with FLAG-tagged Grb10WT or with Bad as a control, because PP2A is known to dephosphorylate Bad (27). The cells were treated with the indicated concentrations of OA (Fig. 1D). Western blot analysis revealed that the mobility shift of Grb10 already occurs in the presence of nanomolar concentrations of OA indicating that PP2A and not PP1 is the phosphatase obligated for Grb10 dephosphorylation (Fig. 1D, top).

To demonstrate that phosphorylation of endogenous Grb10 occurs in vivo, we incubated HeLa cells, either starved or incubated with agents that induce Grb10 phosphorylation, with 32P and performed immunoprecipitations of the corresponding lysates using anti-Grb10 or control antiserum. As depicted in Fig. 1E, phosphorylation of Grb10 was detectable in FCS-stimulated cells and at a reinforced level in cells treated with OA, whereas no phosphorylation was observed in serum-starved cells. The control precipitates did not give rise to unspecific signals. To further substantiate Grb10 phosphorylation, we generated a polyclonal phospho-specific Grb10 antibody raised against a phosphopeptide of Grb10. To test for specificity, we immunoprecipitated Grb10 from lysates derived from HeLa cells that were either serum-starved or stimulated with FCS and processed the respective blot for Western blot analysis. The phospho-Grb10 antiserum detected Grb10 only in the precipitate from FCS-stimulated cells, whereas no signal was observed in the serum-starved sample (Fig. 1F, top). Equal amounts of precipitated Grb10 were detectable in the Grb10 immunostain (Fig. 1F, bottom). We next performed Western blot analysis of lysates derived from HeLa cells that were serum-starved, stimulated with FCS, or treated with OA. As shown in Fig. 1G, top, the phospho-specific antiserum detected Grb10 only when stimulated with FCS and to a even higher extent when treated with OA. Only background signals were detectable in serum-starved cells. The specific phospho-Grb10 signal was abolished upon the addition of the relevant phosphopeptide (Fig. 1G, middle). Of note, an up-shift of Grb10 upon FCS stimulation or treatment with OA was not observed with the endogenous protein as compared with the overexpressed FLAG-tagged Grb10 protein.

A Yeast Two-hybrid Screen Identified 14-3-3 as a New Binding Partner of Grb10 —From our data we hypothesized that Grb10 exists in two different states of phosphorylation that may regulate its interaction with other signaling molecules. To identify such binding proteins, we performed a yeast two-hybrid screen of a K562 cDNA library with a Grb10·LexA fusion protein as bait. In two independent screens the strongest interaction partner of Grb10 was identified to be the {epsilon} isoform of 14-3-3.

To confirm the interaction between Grb10 and 14-3-3 in vitro, we performed GST pull-down assays. We expressed Grb10WT in COS1 cells and were able to precipitate Grb10 with GST-14-3-3 (Fig. 2A). Next, we transiently expressed FLAG-tagged Grb10 and Myc-tagged 14-3-3 in COS1 cells (Fig. 2B) and 293 cells (Fig. 2C) and performed co-immunoprecipitations in both directions. Western blotting revealed a specific interaction between Grb10 and 14-3-3 in both cell lines.



View larger version (19K):
[in this window]
[in a new window]
  		FIG. 2.
14-3-3 is a new interaction partner of Grb10. A, Grb10 WT was expressed transiently in COS1 cells, and GST pull-down assays were performed with GST-14-3-3. B, FLAG-tagged Grb10 and Myc-tagged 14-3-3 were coexpressed in COS1 cells and precipitated with an anti-FLAG antibody. The cell extracts used for the precipitation are shown at the bottom. C, FLAG-tagged Grb10 and Myc-tagged 14-3-3 were coexpressed in 293 cells and precipitated (IP) with an anti-Myc antibody. The cell extracts used for the precipitation are shown at the bottom.

 
Grb10·14-3-3 Interaction Requires Phosphorylation of Grb10— 14-3-3 proteins specifically recognize phosphorylated serine and threonine residues (29) but interact with unphosphorylated proteins as well (21). To investigate whether this interaction is phosphorylation-dependent, we treated Grb10·14-3-3 co-immunoprecipitates with phosphatase. Transiently expressed FLAG-tagged Grb10 and Myc-tagged 14-3-3 in 293 cells were precipitated with an anti-Myc antibody. The precipitated proteins were treated with and without an unspecific phosphatase or with phosphatase together with a specific phosphatase inhibitor (Fig. 3A). The untreated co-immunoprecipitation showed a strong association between Grb10 and 14-3-3 (Fig. 3A, top section, lane labeled Ø). Incubation with the unspecific phosphatase resulted in a greatly diminished interaction between Grb10 and 14-3-3 (Fig. 3A, top section, lanes labeled +/5min and +/10min). The presence of phosphatase inhibitors could partially restore the interaction (Fig. 3A, top section, lane labeled +/5min/+Inhibitor). The second section from the top in Fig. 3A shows equal amounts of precipitated 14-3-3. The center section of Fig. 3A shows the control immunoprecipitation (IP), and the two bottom sections show similar expression levels of Grb10 and 14-3-3 in the cell lysates. These data indicate a requirement of Grb10 phosphorylation for 14-3-3 interaction.



View larger version (36K):
[in this window]
[in a new window]
  		FIG. 3.
Phosphorylation of Grb10 mediates association with 14-3-3. A, 293 cells were transfected with Grb10 and 14-3-3. After 48 h the cells were harvested, and co-immunoprecipitation (IP) experiments were performed. The immunoprecipitated beads were treated with phosphatase for the indicated time periods. The cell extracts used for the precipitations are shown at the bottom. R{alpha}M, rabbit anti-mouse control. B and C, treatment with OA induced the complex formation between Grb10 and 14-3-3 in cells transiently expressing Grb10 and 14-3-3 (B) and in Ba/F3 cells stable expressing Grb10 and endogenous 14-3-3 (C). D, serum stimulation and OA treatment induced complex formation between endogenous 14-3-3 and Grb10. Stimulation with serum and 1 µM OA was carried out for 1 h in serum-starved HeLa cells. Anti-Grb10 immunoprecipitations were analyzed by immunoblotting with an anti-14-3-3 antibody (top) and an anti-Grb10 antibody (bottom). E, proteins were extracted from mouse lung by homogenization. The cell suspensions were incubated with a Grb10 antibody or with a control antibody. The anti-Grb10 immunoprecipitation was analyzed by immunoblotting with an anti-14-3-3 antibody.

 
To emphasize the necessity of Grb10 phosphorylation for 14-3-3 interaction, we treated cells with OA and performed co-immunoprecipitations. Co-immunoprecipitation experiments revealed a greatly enhanced association between 14-3-3 and the hyperphosphorylated form of Grb10 in the presence of OA compared with the interaction between 14-3-3 and Grb10 in untreated cells (Fig. 3B, top section).

Next, we were interested as to whether endogenous 14-3-3 associates with Grb10. Therefore, we stably expressed FLAG-tagged Grb10 or empty vector as a control in Ba/F3 cells. We treated the cells with or without OA and performed co-immunoprecipitation experiments (Fig. 3C). Only the hyperphosphorylated form of Grb10 was able to form a complex with endogenous 14-3-3, whereas we could not detect an interaction between Grb10 and endogenous 14-3-3 in untreated cells. The binding specificity was confirmed by the vector control reaction (Fig. 3C, two lanes labeled PCMVØ). To ascertain the interaction between the endogenous proteins, we stimulated serum starved HeLa cells with serum in the presence of OA and performed co-immunoprecipitations (Fig. 3D). The experiment showed an interaction between endogenous 14-3-3 and endogenous Grb10 only in serum-stimulated cells (Fig. 3D, left sections, two right lanes). Accordingly, 14-3-3 and Grb10 could be coprecipitated from murine lung tissue when a polyclonal antibody was used to immunoprecipitate Grb10 from mouse lung (Fig. 3E, top section).

Interaction of Grb10 and 14-3-3 Is Wortmannin-sensitive— The phosphorylation of Grb10 is PI-3 kinase-dependent (4, 7). Therefore, we tested whether the inhibition of Grb10 phosphorylation through the PI-3kinase inhibitor wortmannin is able to abolish the association between Grb10 and 14-3-3. We transiently co-expressed Grb10 and 14-3-3 and treated the cells with wortmannin. The cells were harvested, and co-immunoprecipitation experiments were performed. Wortmannin treatment reduced the association between Grb10 and 14-3-3 as compared with the Me2SO (DMSO) control (Fig. 4, top section).



View larger version (21K):
[in this window]
[in a new window]
  		FIG. 4.
Grb10 interaction with 14-3-3 is wortmannin-sensitive. 293 cells transiently expressing Grb10 and 14-3-3 were incubated with wortmannin for 30 min. Anti-Myc immunoprecipitates (IP) were analyzed by immunoblotting with an anti-FLAG antibody (top) and an anti-Myc antibody (bottom). R{alpha}M, rabbit anti-mouse control.

 
Identification of Serine 428 in Grb10 as the 14-3-3 Recognition Site—14-3-3 proteins recognize conserved motifs containing phosphoserine such as Arg-X-Arg-X-X-Ser(P)-X-Pro, Arg-Ser-X-Ser(P)-X-Pro, and Arg-X-X-Ser(P). We found two potential 14-3-3 binding sites in Grb10, namely serine 76 within a RXXSXP motif and serine 428 within a RSVSEN motif (Fig. 5A). Both residues were substituted with alanine by site-directed mutagenesis, and the ability of both mutants to bind 14-3-3 was examined. We transfected Grb10 WT, Grb10 S76A, and Grb10 S428A in COS1 cells and performed GST binding studies with GST-14-3-3 (Fig. 5B). Our data indicate that mutation at serine 428 impairs the ability of 14-3-3 to bind Grb10 (Fig. 5B, top section, lane labeled Grb10 S428A). The mutation of serine 76 to alanine did not affect 14-3-3 binding to Grb10 (Fig. 5B, top section, lane labeled Grb10 S76A). As a control, we incubated the Grb10 cell lysates with GST (Fig. 5B, middle section). The cell lysates used in this experiment are shown in Fig. 5B, bottom section.



View larger version (16K):
[in this window]
[in a new window]
  		FIG. 5.
Identification of the 14-3-3 binding motif in Grb10. A, schematic illustration of Grb10. The localization of the potential 14-3-3 binding motifs are indicated as RXXSXP and RSVSEN. B, serine 76 (S76 in panel A) within the RXXSXP 14-3-3 binding motif and serine 428 (S428 in panel A) within the RSVSEN motif were mutated to alanine. GST pull-down assays with GST-14-3-3 and cells expressing both mutants were performed. Comparable amounts of cell lysates were used in the assay (bottom).

 
Grb10 Exists in Two Different States of Phosphorylation, i.e. in the Unphosphorylated Form It May Primarily Associate with Akt, and in the Phosphorylated Form It Interacts with 14-3-3— From our data we propose a hypothetical model in which Grb10 exists in two different states of phosphorylation (Fig. 6B). In the unphosphorylated state, Grb10 interacts with Akt. The Grb10·Akt complex translocates to the plasma membrane, where PDK1/2 phosphorylates Akt. The activated Akt phosphorylates Grb10, the Grb10·Akt complex dissociates, and the interaction with 14-3-3 occurs. The phosphorylation of Grb10 is the requirement for binding to 14-3-3. PP2A dephosphorylates Grb10, mediating dissociation of the Grb10·14-3-3 complex and leading to interaction with Akt.



View larger version (30K):
[in this window]
[in a new window]
  		FIG. 6.
Hypothetical model of a regulatory circuitry involving Grb10, 14-3-3, and Akt. A, COS1 cells were transiently transfected with Akt and Grb10 WT or the Grb10 S428A mutant and with (+) or without (–) 14-3-3 as indicated. Cells were serum-starved, and the cell lysates were analyzed by Western blot analysis with the antibodies indicated. B, in the unphosphorylated state Grb10 preferentially interacts with Akt. Upon receptor stimulation the complex translocates to the plasma membrane, where PDK phosphorylates and activates Akt. The activated Akt phosphorylates Grb10, which then leads to its interaction with 14-3-3. After dephosphorylation, Grb10 may interact with Akt again.

 
To further elucidate this hypothesis, we transfected COS1 cells with Akt, with or without 14-3-3, and with Grb10 WT and Grb10 S428A, the 14-3-3 binding mutant. Western blot analysis with the indicated antibodies revealed that Grb10 WT mediates Akt activation, as we reported previously (7) (Fig. 6A, top section, second lane from the left). However, co-expression of Grb10 and 14-3-3 resulted in a reduced Akt activation (Fig. 6A, top section, second lane from the right). Interestingly, the expression of the Grb10 S428A mutant, which is unable to interact with 14-3-3, seems to result in an enhanced activation of Akt (Fig. 6A, top section, far right lane). This could be explained by the fact that the Grb10 molecule interacts either with Akt or with 14-3-3 in a competing fashion.


   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
By performing a yeast two-hybrid screen we identified the {epsilon} form of 14-3-3 as a new interaction partner of Grb10. We show that Grb10 binds 14-3-3 in vitro and in vivo. It has been shown that Grb10 is phosphorylated on serine/threonine residues (4) and that incubation with the specific PI 3-kinase inhibitor wortmannin abolished Grb10 phosphorylation (4). These data suggested that a kinase downstream of the PI 3-kinase pathway is responsible for Grb10 phosphorylation.

We observed that the Grb10·14-3-3 interaction was diminished after wortmannin treatment, providing evidence that the interaction between Grb10 and 14-3-3 requires the phosphorylation of Grb10. Treatment with wortmannin inhibits the downstream target of PI 3-kinase Akt. In this study, we were able to show a direct interaction between Grb10 and Akt using purified proteins in an in vitro binding assay. Moreover, we demonstrate that Akt is capable of phosphorylating Grb10 in an in vitro kinase assay. Thus, Akt may be the kinase responsible for Grb10 phosphorylation and regulation of the Grb10·14-3-3 complex. The regulation of 14-3-3 interactions with signaling molecules by phosphorylation has been shown previously by other groups. For example, the interaction of 14-3-3 and PDK1 requires phosphorylation of PDK1 (30). Muslin et al. identified a motif for 14-3-3 interactions (Arg-Ser-X-Ser(P)-X-Pro) (19). Recent studies with phosphopeptide libraries revealed that there exist additional preferred motifs for 14-3-3 binding, Arg-X-Arg-X-X-Ser(P)-X-Pro or Arg-X-X-Ser(P) (18). Grb10 contains two potential 14-3-3 binding motifs in its amino acid sequence 73RXXSXP78 and 427RSVSEN432. Site-directed mutagenesis of the target serines revealed that serine 428 within the RSVSEN motif is required for the Grb10·14-3-3 binding. Therefore, we propose that serine 428 within the RSVSEN motif of Grb10 may be one of the phosphorylation sites.

Treatment of cells with the phosphatase inhibitor OA leads to the accumulation of phosphorylated Grb10. Because this accumulation is observed at a nanomolar concentration at which OA is a specific inhibitor of PP2A, this is a likely phosphatase to dephosphorylate Grb10. Binding of 14-3-3 to Grb10 was enhanced in cells treated with OA. In addition, the complex formation between endogenous 14-3-3 and Grb10 was only detectable after stimulation with serum and OA in various cell lines. There exist two explanations for the absent interaction between endogenous Grb10 and 14-3-3 in unstimulated or serum-starved cells. First, the level of Grb10 phosphorylation is too faint and, therefore, the affinity of 14-3-3 to Grb10 is too low. The second explanation involves the subcellular localization of the target protein. Without stimulation the two proteins may exist in two different cell compartments and, therefore, the two proteins could not associate. The fact that GST·14-3-3 pulls down overexpressed Grb10 WT but not the Grb10 S428A mutant from cell lysates argues for the first explanation.

We have previously identified the serine/threonine kinase Akt as a binding partner of the adapter protein Grb10 (7). This interaction mediates the activation of Akt. These data differ from two recent studies by Wick et al. (12) and Langlais et al. (11), who demonstrated that human Grb10{gamma} with an intact PH domain has an inhibitory effect on Akt activation (11, 12). Both studies observed their findings in CHO and HeLa cells, both stably expressing the insulin receptor. To rule out the possibility that the differences in these studies are due to the cell line or the Grb10 construct used, we transiently transfected Akt together with human Grb10{gamma} or murine Grb10. In our hands overexpression of both forms of Grb10 induces an increase in Akt activation compared with that of the vector control in CHO cells (data not shown), although to a lower extent as compared with COS1 or 293 cells. Therefore, we conclude that Grb10 activates Akt in COS1 cells and to a lesser extent in parental CHO cells without expressing the insulin receptor.

Many studies suggest a connection between Akt and 14-3-3. The serine/threonine kinase Akt phosphorylates Bad (13) and FKHRL1 (15), which is the requirement for the interaction of Bad and FKHRL1 with 14-3-3. New insights show that 14-3-3 even interacts directly with Akt (31) and PDK1 (30). The association between 14-3-3 and PDK1 has an inhibitory effect on PDK1 activity, and the authors suggest that 14-3-3 has no effect on the translocation of PDK1. Additionally, the authors propose an inhibitory effect on Akt activity. These data show that 14-3-3 binding can have a direct effect on target protein activity. In addition, previous data characterize 14-3-3 proteins as gatekeepers (32) and show that 14-3-3 can mediate the relocalization of nuclear ligands (33).

In this study we discovered a potential connection between the three proteins Akt, 14-3-3, and Grb10. In a hypothetical model we propose that Grb10 exists in two different states of phosphorylation. In the unphosphorylated state Grb10 interacts with Akt and recruits Akt to the membrane. Akt phosphorylates Grb10, mediating the interaction with 14-3-3. The interaction of phosphorylated Grb10 with 14-3-3 may lead to the translocation of Grb10 back to the cytosol. Here, PP2A could dephosphorylate Grb10 to allow a new interaction with Akt. We observed that the Grb10A428S mutant, which failed to interact with 14-3-3, enhances the activation of Akt as compared with Grb10WT. Therefore, it may also be true that Akt and 14-3-3 compete for the interaction with Grb10. In this scenario, 14-3-3 associates with Grb10 to prohibit the association of Grb10 with Akt.

In summary, our data show that Grb10 interacts specifically with 14-3-3 in a phosphorylation-regulated manner. This interaction may represent an important part of a regulatory circuitry as depicted in Fig. 6B.


   FOOTNOTES
 
* This work was supported by a grant from the Mildred-Scheel Stiftung (to J. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

{ddagger} To whom correspondence should be addressed: Dept. of Internal Medicine III, Laboratory of Leukemogenesis, Technical University of Munich, Ismanigerstr. 22, 81675 Munich, Germany. Tel.: 49-89-4140-4104; Fax: 49-89-4140-7432; E-mail: justus.duyster{at}lrz.tum.de.

1 The abbreviations used are: PH, pleckstrin homology; FCS, fetal calf serum; GST, glutathione S-transferase; OA, okadaic acid; PDK, phosphoinositide-dependent kinase; PP, protein phosphatase; PI, phosphatidylinositol; Pipes, 1,4-piperazinediethanesulfonic acid; Ser(P), phosphoserine; WT, wild type. Back

2 S. Urschel and J. Duyster, submitted for publication. Back



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Daly, R. J. (1998) Cell Signal. 10, 613–618[CrossRef][Medline] [Order article via Infotrieve]
  2. Liu, F., and Roth, R. A. (1998) Mol. Cell. Biochem. 182, 73–78[CrossRef][Medline] [Order article via Infotrieve]
  3. Nantel, A., Huber, M., and Thomas, D. Y. (1999) J. Biol. Chem. 274, 35719–35724[Abstract/Free Full Text]
  4. Dong, L. Q., Du, H., Porter, S. G., Kolakowski, L. F., Jr., Lee, A. V., Mandarino, L. J., Fan, J., Yee, D., Liu, F., and Mandarino, J. (1997) J. Biol. Chem. 272, 29104–29112[Abstract/Free Full Text]
  5. Mano, H., Ohya, K., Miyazato, A., Yamashita, Y., Ogawa, W., Inazawa, J., Ikeda, U., Shimada, K., Hatake, K., Kasuga, M., Ozawa, K., and Kajigaya, S. (1998) Genes Cells 3, 431–441[Abstract]
  6. Langlais, P., Dong, L. Q., Hu, D., and Liu, F. (2000) Oncogene 19, 2895–2903[CrossRef][Medline] [Order article via Infotrieve]
  7. Jahn, T., Seipel, P., Urschel, S., Peschel, C., and Duyster, J. (2002) Mol. Cell. Biol. 22, 979–991[Abstract/Free Full Text]
  8. Wang, J., Dai, H., Yousaf, N., Moussaif, M., Deng, Y., Boufelliga, A., Swamy, O. R., Leone, M. E., and Riedel, H. (1999) Mol. Cell. Biol. 19, 6217–6228[Abstract/Free Full Text]
  9. Liu, F., and Roth, R. A. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 10287–10291[Abstract/Free Full Text]
  10. Deng, Y., Bhattacharya, S., Swamy, O. R., Tandon, R., Wang, Y., Janda, R., and Riedel, H. (2003) J. Biol. Chem. 278, 39311–39322[Abstract/Free Full Text]
  11. Langlais, P., Dong, L. Q., Ramos, F. J., Hu, D., Li, Y., Quon, M. J., and Liu, F. (2003) Mol. Endocrinol. 18, 350–358
  12. Wick, K. R., Werner, E. D., Langlais, P., Ramos, F. J., Dong, L. Q., Shoelson, S. E., and Liu, F. (2003) J. Biol. Chem. 278, 8460–8467[Abstract/Free Full Text]
  13. Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M. E. (1997) Cell 91, 231–241[CrossRef][Medline] [Order article via Infotrieve]
  14. Downward, J. (1999) Nat. Cell Biol. 1, E33–E35[CrossRef][Medline] [Order article via Infotrieve]
  15. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., and Greenberg, M. E. (1999) Cell 96, 857–868[CrossRef][Medline] [Order article via Infotrieve]
  16. Xiao, B., Smerdon, S. J., Jones, D. H., Dodson, G. G., Soneji, Y., Aitken, A., and Gamblin, S. J. (1995) Nature 376, 188–191[CrossRef][Medline] [Order article via Infotrieve]
  17. Liu, D., Bienkowska, J., Petosa, C., Collier, R. J., Fu, H., and Liddington, R. (1995) Nature 376, 191–194[CrossRef][Medline] [Order article via Infotrieve]
  18. Yaffe, M. B., Rittinger, K., Volinia, S., Caron, P. R., Aitken, A., Leffers, H., Gamblin, S. J., Smerdon, S. J., and Cantley, L. C. (1997) Cell 91, 961–971[CrossRef][Medline] [Order article via Infotrieve]
  19. Muslin, A. J., Tanner, J. W., Allen, P. M., and Shaw, A. S. (1996) Cell 84, 889–897[CrossRef][Medline] [Order article via Infotrieve]
  20. Hausser, A., Storz, P., Link, G., Stoll, H., Liu, Y. C., Altman, A., Pfizenmaier, K., and Johannes, F. J. (1999) J. Biol. Chem. 274, 9258–9264[Abstract/Free Full Text]
  21. Masters, S. C., Pederson, K. J., Zhang, L., Barbieri, J. T., and Fu, H. (1999) Biochemistry 38, 5216–5221[CrossRef][Medline] [Order article via Infotrieve]
  22. Bai, R. Y., Jahn, T., Schrem, S., Munzert, G., Weidner, K. M., Wang, J. Y., and Duyster, J. (1998) Oncogene 17, 941–948[CrossRef][Medline] [Order article via Infotrieve]
  23. Duyster, J., Baskaran, R., and Wang, J. Y. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 1555–1559[Abstract/Free Full Text]
  24. O'Kelly, I., Butler, M. H., Zilberberg, N., and Goldstein, S. A. (2002) Cell 111, 577–588[CrossRef][Medline] [Order article via Infotrieve]
  25. Deleted in proof
  26. Deleted in proof
  27. Chiang, C. W., Harris, G., Ellig, C., Masters, S. C., Subramanian, R., Shenolikar, S., Wadzinski, B. E., and Yang, E. (2001) Blood 97, 1289–1297[Abstract/Free Full Text]
  28. Deleted in proof
  29. Michaud, N. R., Fabian, J. R., Mathes, K. D., and Morrison, D. K. (1995) Mol. Cell. Biol. 15, 3390–3397[Abstract]
  30. Sato, S., Fujita, N., and Tsuruo, T. (2002) J. Biol. Chem. 277, 39360–39367[Abstract/Free Full Text]
  31. Powell, D. W., Rane, M. J., Chen, Q., Singh, S., and McLeish, K. R. (2002) J. Biol. Chem. 277, 21639–21642[Abstract/Free Full Text]
  32. Yaffe, M. B. (2002) FEBS Lett. 513, 53–57[CrossRef][Medline] [Order article via Infotrieve]
  33. Brunet, A., Kanai, F., Stehn, J., Xu, J., Sarbassova, D., Frangioni, J. V., Dalal, S. N., DeCaprio, J. A., Greenberg, M. E., and Yaffe, M. B. (2002) J. Cell Biol. 156, 817–828[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
S. Kebache, J. Ash, M. G. Annis, J. Hagan, M. Huber, J. Hassard, C. L. Stewart, M. Whiteway, and A. Nantel
Grb10 and Active Raf-1 Kinase Promote Bad-dependent Cell Survival
J. Biol. Chem., July 27, 2007; 282(30): 21873 - 21883.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Leon, D. Nandan, M. Lopez, A. Moeenrezakhanlou, and N. E. Reiner
Annexin V Associates with the IFN-{gamma} Receptor and Regulates IFN-{gamma} Signaling
J. Immunol., May 15, 2006; 176(10): 5934 - 5942.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/17/16987    most recent
M501477200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Urschel, S.
Right arrow Articles by Duyster, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Urschel, S.
Right arrow Articles by Duyster, J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.